Cargando…
Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus
BACKGROUND: Although disease remission can frequently be achieved for patients with neuroblastoma, relapse is common. The cancer stem cell theory suggests that rare tumorigenic cells, resistant to conventional therapy, are responsible for relapse. If true for neuroblastoma, improved cure rates may o...
Autores principales: | Mahller, Yonatan Y., Williams, Jon P., Baird, William H., Mitton, Bryan, Grossheim, Jonathan, Saeki, Yoshinaga, Cancelas, Jose A., Ratner, Nancy, Cripe, Timothy P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626279/ https://www.ncbi.nlm.nih.gov/pubmed/19156211 http://dx.doi.org/10.1371/journal.pone.0004235 |
Ejemplares similares
-
Progress of oncolytic virotherapy for neuroblastoma
por: Chen, Xiao-Tong, et al.
Publicado: (2022) -
Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24
por: Mazar, Joseph, et al.
Publicado: (2018) -
Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?
por: Denton, Nicholas L., et al.
Publicado: (2016) -
VEGF Blockade Decreases Tumor Uptake of Systemic Oncolytic Herpes Virus but Enhances Therapeutic Efficacy When Given After Virotherapy
por: Eshun, Francis K., et al.
Publicado: (2010) -
Expression of HSV-1 Receptors in EBV-Associated Lymphoproliferative Disease Determines Susceptibility to Oncolytic HSV
por: Wang, Pin-Yi, et al.
Publicado: (2012)